Literature DB >> 32004514

Cannabinoids in the descending pain modulatory circuit: Role in inflammation.

Courtney A Bouchet1, Susan L Ingram2.   

Abstract

The legalization of cannabis in some states has intensified interest in the potential for cannabis and its constituents to lead to novel therapeutics for pain. Our understanding of the cellular mechanisms underlying cannabinoid actions in the brain have lagged behind opioids; however, the current opioid epidemic has also increased attention on the use of cannabinoids as alternatives to opioids for pain, especially chronic pain that requires long-term use. Endogenous cannabinoids are lipid signaling molecules that have complex roles in modulating neuronal function throughout the brain. In this review, we discuss cannabinoid functions in the descending pain modulatory pathway, a brain circuit that integrates cognitive and emotional processing of pain to modulate incoming sensory inputs. In addition, we highlight areas where further studies are necessary to understand cannabinoid regulation of descending pain modulation.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Analgesia; Cannabinoid; Endocannabinoid; Pain; Periaqueductal gray; Presynaptic terminals; Rostral ventromedial medulla

Mesh:

Substances:

Year:  2020        PMID: 32004514      PMCID: PMC7183429          DOI: 10.1016/j.pharmthera.2020.107495

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  229 in total

1.  The Lysophosphatidylinositol Receptor GPR55 Modulates Pain Perception in the Periaqueductal Gray.

Authors:  Elena Deliu; Margaret Sperow; Linda Console-Bram; Rhonda L Carter; Douglas G Tilley; Daniel J Kalamarides; Lynn G Kirby; G Cristina Brailoiu; Eugen Brailoiu; Khalid Benamar; Mary E Abood
Journal:  Mol Pharmacol       Date:  2015-05-13       Impact factor: 4.436

2.  Rostral ventromedial medulla μ, but not κ, opioid receptors are involved in electroacupuncture anti-hyperalgesia in an inflammatory pain rat model.

Authors:  Yu Zhang; Aihui Li; Lixing Lao; Jiajia Xin; Ke Ren; Brian M Berman; Rui-Xin Zhang
Journal:  Brain Res       Date:  2011-04-28       Impact factor: 3.252

Review 3.  Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review.

Authors:  Kevin P Hill
Journal:  JAMA       Date:  2015 Jun 23-30       Impact factor: 56.272

4.  Postsynaptic actions of substance P on rat periaqueductal grey neurons in vitro.

Authors:  Geoffrey M Drew; Vanessa A Mitchell; Christopher W Vaughan
Journal:  Neuropharmacology       Date:  2005-10       Impact factor: 5.250

5.  Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.

Authors:  P M Zygmunt; J Petersson; D A Andersson; H Chuang; M Sørgård; V Di Marzo; D Julius; E D Högestätt
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

6.  Increased tonic cannabinoid CB1R activity and brain region-specific desensitization of CB1R Gi/o signaling axis in mice with global genetic knockout of monoacylglycerol lipase.

Authors:  Dina Navia-Paldanius; Niina Aaltonen; Marko Lehtonen; Juha R Savinainen; Ulrike Taschler; Franz P W Radner; Robert Zimmermann; Jarmo T Laitinen
Journal:  Eur J Pharm Sci       Date:  2015-06-09       Impact factor: 4.384

7.  Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems.

Authors:  Daniela Viganò; Tiziana Rubino; Angelo Vaccani; Silvia Bianchessi; Patrick Marmorato; Chiara Castiglioni; Daniela Parolaro
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

Review 8.  Endocannabinoid signaling and synaptic function.

Authors:  Pablo E Castillo; Thomas J Younts; Andrés E Chávez; Yuki Hashimotodani
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

9.  Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors.

Authors:  Wei Xiong; Tanxing Cui; Kejun Cheng; Fei Yang; Shao-Rui Chen; Dan Willenbring; Yun Guan; Hui-Lin Pan; Ke Ren; Yan Xu; Li Zhang
Journal:  J Exp Med       Date:  2012-05-14       Impact factor: 14.307

Review 10.  CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity.

Authors:  Arnau Busquets-Garcia; Jaideep Bains; Giovanni Marsicano
Journal:  Neuropsychopharmacology       Date:  2017-09-01       Impact factor: 7.853

View more
  5 in total

Review 1.  Cannabis for Rheumatic Disease Pain: a Review of Current Literature.

Authors:  William Benjamin Nowell; Kelly Gavigan; Stuart L Silverman
Journal:  Curr Rheumatol Rep       Date:  2022-04-29       Impact factor: 4.686

Review 2.  Alternative pain management via endocannabinoids in the time of the opioid epidemic: Peripheral neuromodulation and pharmacological interventions.

Authors:  Ming Tatt Lee; Ken Mackie; Lih-Chu Chiou
Journal:  Br J Pharmacol       Date:  2021-12-07       Impact factor: 9.473

3.  Cannabinoids: A New Perspective on Epileptogenesis and Seizure Treatment in Early Life in Basic and Clinical Studies.

Authors:  Angélica Vega-García; Iris Feria-Romero; Anais García-Juárez; Ana Ch Munguia-Madera; Alexia V Montes-Aparicio; Esli Zequeida-Muñoz; Estefany Garcia-Albavera; Sandra Orozco-Suárez
Journal:  Front Behav Neurosci       Date:  2021-01-12       Impact factor: 3.558

4.  Inhibition of Nociception in a Preclinical Episodic Migraine Model by Dietary Supplementation of Grape Seed Extract Involves Activation of Endocannabinoid Receptors.

Authors:  Sara E Woodman; Sophia R Antonopoulos; Paul L Durham
Journal:  Front Pain Res (Lausanne)       Date:  2022-01-27

Review 5.  Cellular and circuit diversity determines the impact of endogenous opioids in the descending pain modulatory pathway.

Authors:  Kylie B McPherson; Susan L Ingram
Journal:  Front Syst Neurosci       Date:  2022-08-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.